Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity
2010
Findings suggest that the efficacy of antibody-based therapy of solid tumors can be improved by engineering changes in the antibody constant region that enhance ADCC.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
50
References
20
Citations
NaN
KQI